Publications by authors named "Hani Al-Asaad"
Article Synopsis
- The study aimed to compare the effectiveness and safety of two medications, colesevelam and ezetimibe, for lowering LDL cholesterol in patients with type 2 diabetes who have uncontrolled blood sugar levels.
- Over 24 weeks, 200 patients were randomly assigned to receive either medication, with the goal of reaching specific LDL and HbA1c levels; results showed similar effectiveness in reaching these targets.
- Ezetimibe resulted in a greater reduction in LDL cholesterol and fewer side effects compared to colesevelam, making it a more tolerable option for patients.
Background And Objectives: Because there is no recent update on the state of diabetes and its concomitant complications in Saudi Arabia, we undertook a study of the prevalence of health complications in patients with type 2 diabetes mellitus admitted to our institution.
Methods: We conducted a retrospective review of medical records of adult Saudi patients with type 2 diabetes who were seen in clinics or admitted to the Security Forces Hospital, Riyadh, Saudi Arabia, between January 1989 and January 2004.
Results: Of 1952 patients, 943 (48.